BeStock  
Stocks › Biotechnology › OCS

Oculis OCS

US equityMarket cap rank #3648Biotechnology
$7.06 −$0.38 (-5.11%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $7.06 0.00%
Open$7.38
Prev close$7.44
Day range$6.98 – $7.43
Volume235.2K
Market cap$437.15M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership47.5%+0.81 pts vs. prior quarter
Institutions holding76+2 vs. prior quarter
Insider trades (recent)0 buys / 1 sellsNet selling
Short interest2.57% of floatDays to cover 5.6 · as of 30 Oct 2026
Short-sale volume share14.2%5-day average of daily volume

Short-sale volume as % of daily volume

7%13%19%26%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$135.2K (13 inflow days, 7 outflow days).

Net flow by order size, last 20 sessions

−$172.8KSuper+$37.6KBig−$56.8KMid−$603.8KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 26.1% of shares outstanding.

Largest holders

  • Eqt Fund Management S.à R.L.11.26%
  • BVCF Management Ltd3.95%
  • Gildi - lífeyrissjódur3.94%
  • abrdn plc3.69%
  • Millennium Management LLC3.31%
  • Pivotal BioVenture Partners LLC2.93%
  • Riad Sherif2.13%
  • Citadel Advisors LLC1.60%

By investor type

  • VC/PE Fund21.49%
  • Hedge Fund11.11%
  • Mutual Fund10.27%
  • Corporate Pension Plan3.94%
  • Individual/Insider3.87%
  • Public Company0.38%
  • Private Company0.26%
  • Family Office/Trust0.03%

Reported short interest has risen from 2.37% to 2.57% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Franklin Resources Mutual Fund 2026/Q3 +462,413 1.5%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +118,629 0.2%
abrdn plc Mutual Fund 2026/Q3 +118,564 3.7%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +54,024 0.2%
Barclays PLC Public Company 2026/Q3 +33,644 0.1%
Millennium Management LLC Hedge Fund 2026/Q3 +1,129,433 3.3%
Eqt Fund Management S.à R.L. VC/PE Fund 2026/Q3 +1,050,000 11.3%
Braidwell LP Hedge Fund 2026/Q3 +834,183 1.4%
Citadel Advisors LLC Hedge Fund 2026/Q3 +825,920 1.6%
Artal Group S.A. VC/PE Fund 2026/Q3 +625,000 1.0%
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q3 +619,922 1.0%
PFM Health Sciences, LP Hedge Fund 2026/Q3 +436,042 0.7%
Franklin Resources Mutual Fund 2026/Q3 +434,751 0.7%
Candriam, Société En Commandite Par Actions Mutual Fund 2026/Q3 +420,542 0.7%
abrdn plc Mutual Fund 2026/Q3 +412,863 3.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
8 Oct 2025 Christina Ackermann Independent Director Intent to Sell (Form 144) -7,460 $19.87 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 1,583,743 2.6% 5.6
15 Oct 2026 1,786,384 2.9% 4.8
30 Sep 2026 1,770,457 2.9% 6.5
15 Sep 2026 1,551,805 2.5% 9.9
31 Aug 2026 1,490,077 2.4% 9.1
14 Aug 2026 1,460,411 2.4% 5.3

Discussion

No comments yet — be the first to weigh in on OCS.

Sign in to join the discussion.

Scroll to Top